Clinical trials
Recruiting Phase 2/3 trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 21 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 6 |
| Monash University | 5 |
| AbbVie | 4 |
| Janssen Research & Development, LLC | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Eikon Therapeutics | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Takeda | 2 |
| University of Melbourne | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Infections | 5 |
| Leukemia | 5 |
| Lymphoma | 5 |
| Neoplasms, Plasma Cell | 5 |
| Neoplasm Metastasis | 4 |
| Alzheimer Disease | 2 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.